Metabolic syndrome food formulation study, Dr. Schär AG sponsor
Summary
The National Library of Medicine's ClinicalTrials.gov registered a new clinical trial (NCT07505277) sponsored by Dr. Schär AG investigating a food formulation intervention for metabolic syndrome. The study is listed as 'Not yet recruiting' on the registry.
What changed
A new clinical trial has been registered on ClinicalTrials.gov under identifier NCT07505277. The study will investigate a food formulation intervention for metabolic syndrome and is sponsored by Dr. Schär AG, a European food company. The trial is currently listed as 'Not yet recruiting.'\n\nFood manufacturers and healthcare providers conducting clinical research on metabolic syndrome or related conditions should ensure their applicable trials are registered on ClinicalTrials.gov per FDAAA 801 requirements. Registration is mandatory for certain trials involving FDA-regulated products with specified intervention types and phases. Non-compliance may result in civil penalties of up to $10,000 per day.
What to do next
- Verify if other clinical trials require registration under FDAAA 801
- Ensure applicable trials testing food formulations for health claims are registered on ClinicalTrials.gov
- Monitor FDAAA 801 compliance requirements for trials involving metabolic syndrome interventions
Penalties
Civil penalties up to $10,000 per day for failure to register applicable trials under FDAAA 801
Source document (simplified)
Show glossary
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ClinicalTrials.gov publishes new changes.